AlphaStocks
5.9
Consider Buy

Corvel Corp (CRVL)

As of Sep 20, 2026, Corvel Corp (CRVL) scores 5.9/10 on AlphaStocks' five-model composite, #53 of 168 Health Care stocks. At $71, CRVL trades 58% above its model fair value of $45.

Health Care / Health Care Services

S&P SmallCap 600

$70.51

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 2 of 5 models — limited data

Data as of Sep 20, 2026

#53out of 168 in Health Care

Is CORVEL CORP a Good Investment in 2026?

CORVEL CORP (CRVL) scores 5.9 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates CORVEL CORP as Attractive (6/9). However, the Graham model rates it Caution — Significantly above fair value. CORVEL CORP currently trades 58% above its estimated fair value of $45. CORVEL CORP ranks #53 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E33.0ROE11.1Market Cap4B

Estimated Fair Value

$44.7258% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Limited Data

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is CORVEL CORP (CRVL) a good investment?
As of Sep 20, 2026, Corvel Corp (CRVL) scores 5.9/10 on AlphaStocks' five-model composite, #53 of 168 Health Care stocks. At $71, CRVL trades 58% above its model fair value of $45. That is a middle-of-the-pack score with no strong signal either way.
What is CORVEL CORP's Piotroski F-Score?
CORVEL CORP's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CRVL overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $45, CRVL appears overvalued. The stock currently trades 58% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does CRVL compare to other Health Care stocks?
CORVEL CORP ranks #53 out of 168 stocks in the Health Care sector, placing it in the top 32% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about CRVL?
AlphaStocks evaluates CRVL using five proven investment models. Piotroski: Attractive; Graham: Caution. These models are combined into a single composite score of 5.9/10.

Similar Stocks

DVAMDDGX

Compare CRVL with

CRVL vs DVACRVL vs MDCRVL vs DGXCRVL vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer